Evidence
Alzheimers Dement (Amst). 2023 Dec 22;15(4):e12515. doi: 10.1002/dad2.12515. eCollection 2023 Oct-Dec.
ABSTRACT
INTRODUCTION: 18F-Fluoro-deoxyglucose-positron emission tomography (FDG-PET) is a supportive biomarker in dementia with Lewy bodies (DLB) diagnosis and its advanced analysis methods, including radiomics and machine learning (ML), were developed recently. The aim of this study was to evaluate the FDG-PET diagnostic performance in predicting a DLB versus Alzheimer’s disease (AD) diagnosis.
METHODS: FDG-PET scans were visually and semi-quantitatively analyzed in 61 patients. Radiomics and ML analyses were performed, building five ML models: (1) clinical features; (2) visual and semi-quantitative PET features; (3) radiomic features; (4) all PET features; and (5) overall features.
RESULTS: At follow-up, 34 patients had DLB and 27 had AD. At visual analysis, DLB PET signs were significantly more frequent in DLB, having the highest diagnostic accuracy (86.9%). At semi-quantitative analysis, the right precuneus, superior parietal, lateral occipital, and primary visual cortices showed significantly reduced uptake in DLB. The ML model 2 had the highest diagnostic accuracy (84.3%).
DISCUSSION: FDG-PET is a valuable tool in DLB diagnosis, having visual and semi-quantitative analyses with the highest diagnostic accuracy at ML analyses.
PMID:38145190 | PMC:PMC10746864 | DOI:10.1002/dad2.12515
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Combined 18F-FDG PET-CT markers in dementia with Lewy bodies
🌐 90 Days
VR Related Evidence Matrix
- Diagnostic performance of molecular imaging methods in predicting the progression from mild cognitive impairment to dementia: an updated systematic review
- Clinical Arterial Spin-Labeling MR Imaging to Screen for Typical and Atypical Neurodegenerative Disease in the New Era of Alzheimer Treatment
- Diagnostic performance of a deep-learning model using 18F-FDG PET/CT for evaluating recurrence after radiation therapy in patients with lung cancer
- Brain 18 F-FDG PET reveals cortico-subcortical hypermetabolic dysfunction in juvenile neuropsychiatric systemic lupus erythematosus
- The application of different machine learning models based on PET/CT images and EGFR in predicting brain metastasis of adenocarcinoma of the lung
- Clinicoradiological and neuropathological evaluation of primary progressive aphasia
- Development of Pyridothiophene Compounds for PET Imaging of α-Synuclein
- Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer's Disease: A Pragmatic Review for Clinicians
- FDG PET/CT in the Diagnosis and After Sunitinib Follow-up of Synchronous Base of Tongue and Thyroid Metastases From Renal Cell Carcinoma
- Diagnostic efficacy of [68Ga]Ga-DOTA-GPFAPI-04 in patients with solid tumors in a head-to-head comparison with [18F]F-FDG: results from a prospective clinical study
- Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease
- In vivo PET classification of tau pathologies in patients with frontotemporal dementia
- Association of beta-Amyloid, Microglial Activation, Cortical Thickness, and Metabolism in Older Adults Without Dementia
- Detecting High-Dose Methotrexate-Induced Brain Changes in Pediatric and Young Adult Cancer Survivors Using [18F]FDG PET/MRI: A Pilot Study
- A novel method for PET connectomics guided by fibre-tracking MRI: Application to Alzheimer's disease
- Extracting value from total-body PET/CT image data - the emerging role of artificial intelligence
- Multimodal brain age prediction using machine learning: combining structural MRI and 5-HT2AR PET-derived features
- Optimal [18F]FDG PET/CT Cutoff for Pathologic Complete Response in HER2-Positive Early Breast Cancer Patients Treated with Neoadjuvant Trastuzumab and Pertuzumab in the PHERGain Trial
- Data-driven subtypes of mixed semantic-logopenic primary progressive aphasia: Linguistic features, biomarker profiles and brain metabolic patterns
- Prevalence, distribution, and severity of cerebral amyloid angiopathy differ between Lewy body diseases and Alzheimer's disease
- Social relationships, amyloid burden, and dementia: The ARIC-PET study
- Predicting functional decline in aging and Alzheimer's disease with PET-based Braak staging
- Influences of amyloid-beta and tau on white matter neurite alterations in dementia with Lewy bodies
- PET Imaging to Measure Neuroinflammation In Vivo
- Pathophysiology characterization of Alzheimer's disease in South China's aging population: for the Greater-Bay-Area Healthy Aging Brain Study (GHABS)
- Patient- and proxy-reported quality of life in advanced dementia with Lewy bodies
- Deep learning-based whole-body PSMA PET/CT attenuation correction utilizing Pix-2-Pix GAN
- Machine learning prediction of future amyloid beta positivity in amyloid-negative individuals
- Machine learning prediction of future amyloid beta positivity in amyloid-negative individuals
- MRI and 18F-FET PET for Multimodal Treatment Monitoring in Patients with Brain Metastases: A Cost-Effectiveness Analysis
- Conjugal Synucleinopathies: A Clinicopathologic Study
- Conjugal Synucleinopathies: A Clinicopathologic Study
- Common anesthetic used in preclinical PET imaging inhibits metabolism of the PET tracer [18F]3F4AP
- Machine Learning in Diagnosis and Prognosis of Lung Cancer by PET-CT
- Postural control characteristics in Alzheimer's disease, dementia with Lewy bodies, and vascular dementia
- Effect of a Single-Session Mindfulness-Based Swinging Technique (MBST) Intervention on Emotional Distress in Cancer Patients Undergoing PET-CT Scan: A Randomized Controlled Trial
- Quantitative Brain Amyloid PET
- Latest advances in mechanisms of epileptic activity in Alzheimer's disease and dementia with Lewy Bodies
- Generating PET scan patterns in Alzheimer's by a mathematical model
- Association between retinal microvascular abnormalities and late-life brain amyloid-b deposition: the ARIC-PET study
- Neuropsychiatric profiles and cerebral amyloid burden in adults without dementia
- Predicting oxygen needs in COVID-19 patients using chest radiography multi-region radiomics
- Short-latency afferent inhibition as a biomarker of cholinergic degeneration compared to PET imaging in Parkinson's disease
- Assessment of neurovascular uncoupling: APOE status is a key driver of early metabolic and vascular dysfunction
- Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease
- Ranking and filtering of neuropathology features in the machine learning evaluation of dementia studies
- Contribution of Global Amyloid-PET Imaging for Predicting Future Cognition in the MEMENTO Cohort
- A neuroimaging measure to capture heterogeneous patterns of atrophy in Parkinson's disease and dementia with Lewy bodies
- Subsequent correlated changes in complement component 3 and amyloid beta oligomers in the blood of patients with Alzheimer's disease
- Grey matter networks in women and men with dementia with Lewy bodies
- Deep brain stimulation of the amygdala for treatment-resistant combat post-traumatic stress disorder: Long-term results
- Kinetic modeling of the monoamine oxidase-B radioligand [(18)F]SMBT-1 in human brain with positron emission tomography
- The Importance of PET Imaging to Understanding Whole-Body Cortisol Metabolism in Alzheimer's Disease
- Synaptic loss and its association with symptom severity in Parkinson's disease
- Neuroinflammation in dementia: A meta-analysis of PET imaging studies
- PSMA-positive prostatic volume prediction with deep learning based on T2-weighted MRI
- Applications of PET and SPECT in Patients with Autism Spectrum Disorder
- Phenoconversion in pure autonomic failure: a multicentre prospective longitudinal cohort study
- High Contrast PET Imaging of Subcortical and Allocortical Amyloid-β in Early Alzheimer's Disease Using [11C]AZD2184
- Case report: Environmental adjustment for visual hallucinations in dementia with Lewy bodies based on photo assessment of the living environment
- Plasma Leptin and Alzheimer Protein Pathologies Among Older Adults
- Altered TFEB subcellular localization in nigral neurons of subjects with incidental, sporadic and GBA-related Lewy body diseases
- Integration of Cine-cardiac Magnetic Resonance Radiomics and Machine Learning for Differentiating Ischemic and Dilated Cardiomyopathy
- Identification of patients with internet gaming disorder via a radiomics-based machine learning model of subcortical structures in high-resolution T1-weighted MRI
Evidence Blueprint
Combined 18F-FDG PET-CT markers in dementia with Lewy bodies
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Combined 18F-FDG PET-CT markers in dementia with Lewy bodies
🌐 365 Days
VR Related Evidence Matrix
- Identifying Mixed Dementia With Lewy Bodies and Alzheimer Disease Using Multitracer PET Imaging: A Case Study
- MRI or 18F-FDG PET for Brain Age Gap Estimation: Links to Cognition, Pathology, and Alzheimer Disease Progression
- Performance of a [18F]Flortaucipir PET Visual Read Method Across the Alzheimer Disease Continuum and in Dementia With Lewy Bodies
- Dopamine transporter positron emission tomography in patients with Alzheimer's disease with Lewy body disease features
- Diagnostic performance of molecular imaging methods in predicting the progression from mild cognitive impairment to dementia: an updated systematic review
- Clinical Arterial Spin-Labeling MR Imaging to Screen for Typical and Atypical Neurodegenerative Disease in the New Era of Alzheimer Treatment
- A 3D convolutional neural network to classify subjects as Alzheimer's disease, frontotemporal dementia or healthy controls using brain 18F-FDG PET
- Diagnostic performance of a deep-learning model using 18F-FDG PET/CT for evaluating recurrence after radiation therapy in patients with lung cancer
- FDG-PET markers of heterogeneity and different risk of progression in amnestic MCI
- Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS)
- White matter hyperintensity volume modifies the association between CSF vascular inflammatory biomarkers and regional FDG-PET along the Alzheimer's disease continuum
- Targeted examination of amyloid beta and tau protein accumulation via positron emission tomography for the differential diagnosis of Alzheimer's disease based on the A/T(N) research framework
- Impact of different reconstruction algorithms and setting parameters on radiomics features of PSMA PET images: A preliminary study
- Cardiac noradrenergic deficiency revealed by 18F-dopamine positron emission tomography identifies preclinical central Lewy body diseases
- Application of Suggestive Biomarkers in Dementia With Lewy Bodies With Masking of Typical Clinical Symptoms by Alzheimer Disease-type Pathology
- In vivo PET of synaptic density as potential diagnostic marker for cognitive disorders: prospective comparison with current imaging markers for neuronal dysfunction and relation to symptomatology - study protocol
- Brain 18 F-FDG PET reveals cortico-subcortical hypermetabolic dysfunction in juvenile neuropsychiatric systemic lupus erythematosus
- β-Amyloid Load on PET Along the Continuum of Dementia With Lewy Bodies
- Assessing network degeneration and phenotypic heterogeneity in genetic frontotemporal lobar degeneration by decoding FDG-PET
- Hybrid PET/MRI with Flutemetamol and FDG in Alzheimer's Disease Clinical Continuum
- Utility of amyloid PET Imaging in a Memory Clinic
- Relationship between Neuroimaging and Cognition in Frontotemporal Dementia: A [ 18 F]FDG PET and Structural MRI Study
- Occipital atrophy signature in prodromal Lewy bodies disease
- Distinct subtypes of spatial brain metabolism patterns in Alzheimer's disease identified by deep learning-based FDG PET clusters
- Validation of a pharmacological imaging challenge using 11C-buprenorphine and 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography to study the effects of buprenorphine to the rat brain
- The application of different machine learning models based on PET/CT images and EGFR in predicting brain metastasis of adenocarcinoma of the lung
- Performance of the Lumipulse plasma Aβ42/40 and pTau181 immunoassays in the detection of amyloid pathology
- Associations of the A/T/N profiles in PET, CSF, and plasma biomarkers with Alzheimer's disease neuropathology at autopsy
- Clinicoradiological and neuropathological evaluation of primary progressive aphasia
- Suspecting Non-Alzheimer's Pathologies and Mixed Pathologies: A Comparative Study Between Brain Metabolism and Tau Images
- Multifocal hypometabolic correlates to deficits of verbal memory in mesial temporal lobe epilepsy
- A protein panel in cerebrospinal fluid for diagnostic and predictive assessment of Alzheimer's disease
- Deep learning application for the classification of Alzheimer's disease using 18F-flortaucipir (AV-1451) tau positron emission tomography
- Assessment of synaptic loss in mouse models of β-amyloid and tau pathology using [18F]UCB-H PET imaging
- Development of Pyridothiophene Compounds for PET Imaging of α-Synuclein
- Longitudinal motor decline in dementia with Lewy bodies, Parkinson disease dementia, and Alzheimer's dementia in a community autopsy cohort
- CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease
- ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium
- Evaluating the Diagnostic Efficacy of 99mTc-Methionine Single-Photon Emission Computed Tomography-Computed Tomography: A Head-to-Head Comparison with 11C-Methionine Positron Emission Tomography-Magnetic Resonance Imaging in Glioma Patients
- Characteristics of discordance between amyloid positron emission tomography and plasma amyloid-β 42/40 positivity
- Visualization of Thromboinflammation by 18F-DPA-714 PET in a Stroke Patient
- Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer's Disease: A Pragmatic Review for Clinicians
- FDG PET/CT in the Diagnosis and After Sunitinib Follow-up of Synchronous Base of Tongue and Thyroid Metastases From Renal Cell Carcinoma
- Diagnostic efficacy of [68Ga]Ga-DOTA-GPFAPI-04 in patients with solid tumors in a head-to-head comparison with [18F]F-FDG: results from a prospective clinical study
- Prevalence and Clinical Implications of a β-Amyloid-Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease
- Elevated Amyloid-β PET Scan and Cognitive and Functional Decline in Mild Cognitive Impairment and Dementia of Uncertain Etiology
- Profiling of plasma biomarkers in the context of memory assessment in a tertiary memory clinic
- Dynamic Human Brain Imaging with a Portable PET Camera: Comparison to a Standard Scanner
- Morphological characteristics differentiate dementia with Lewy bodies from Parkinson disease with and without dementia
- Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease
- Dementia with Lewy bodies: old and new knowledge - Part 1: clinical aspects and diagnostics
- Elecsys Cerebrospinal Fluid Immunoassays Accurately Detect Alzheimer's Disease Regardless of Concomitant Small Vessel Disease
- A pilot study to evaluate the effect of CT1812 treatment on synaptic density and other biomarkers in Alzheimer's disease
- The microRNA-485-3p concentration in salivary exosome-enriched extracellular vesicles is related to amyloid β deposition in the brain of patients with Alzheimer's disease
- The microRNA-485-3p concentration in salivary exosome-enriched extracellular vesicles is related to amyloid β deposition in the brain of patients with Alzheimer's disease
- In vivo PET classification of tau pathologies in patients with frontotemporal dementia
- Longitudinal blood biomarker trajectories in preclinical Alzheimer's disease
- A systematic review on machine learning and deep learning techniques in the effective diagnosis of Alzheimer's disease
- Association of beta-Amyloid, Microglial Activation, Cortical Thickness, and Metabolism in Older Adults Without Dementia
- Plasma and CSF concentrations of N-terminal tau fragments associate with in vivo neurofibrillary tangle burden
- Detecting High-Dose Methotrexate-Induced Brain Changes in Pediatric and Young Adult Cancer Survivors Using [18F]FDG PET/MRI: A Pilot Study
- A novel method for PET connectomics guided by fibre-tracking MRI: Application to Alzheimer's disease
- Automatic synthesis of 18F-AV-45 and its clinical application in Alzheimer's disease
- Extracting value from total-body PET/CT image data - the emerging role of artificial intelligence